Consensus Clarivate Plc

Equities

CLVT

JE00BJJN4441

Market Closed - Nyse Other stock markets 04:00:04 2024-04-23 pm EDT			5-day change	1st Jan Change
7.14 ^USD	-0.14%		+5.15%	-22.89%

Apr. 23	Clarivate Plc acquired Global QMS, Inc.	CI
Mar. 21	Clarivate to Acquire Substantial Majority of MotionHall's Assets	MT

Evolution of the average Target Price on Clarivate Plc

Price target over the last 5 years

History of analyst recommendation changes

c71.gulMZ_gGwZ3sjHwOmrEHLFTQTo0Jj2TP_uKDffCxZUY.3YwVCb9Z9NeKxAZcqvZgT2aKeNRzwQClhrX2N6fSPyfnhgY2kTbxrLrbDw~db4995925289e92805087f81bb1b8a3a

Analyst Recommendations on Clarivate Plc

Barclays Trims Price Target on Clarivate to $6 From $7, Maintains Underweight Rating	Feb. 28	MT
Oppenheimer Trims Clarivate Price Target to $10 From $11, Maintains Outperform Rating	Feb. 28	MT
RBC Cuts Price Target on Clarivate to $8 From $10, Cites Limited Visibility on Second-Half Turnaround; Sector Perform Kept	Feb. 28	MT
RBC Raises Price Target on Clarivate to $10 From $8, Expects Return to Growth in 2024, Keeps Sector Perform Rating	Jan. 22	MT
Oppenheimer Ups Price Target on Clarivate to $11 From $10, Keeps Outperform Rating	Jan. 08	MT
Wells Fargo Downgrades Clarivate to Underweight From Equalweight, Price Target is $8	Dec. 15	MT
Oppenheimer Adjusts Clarivate Price Target to $10 From $11, Maintains Outperform Rating	23-10-05	MT
Citigroup Cuts Price Target on Clarivate to $8 From $10, Maintains Neutral Rating	23-09-26	MT
Barclays Downgrades Clarivate to Underweight From Equal Weight, Adjusts Price Target to $7 From $8	23-09-08	MT
RBC Downgrades Clarivate to Sector Perform From Outperform, Says Potential for Strategic Optionality has Declined, Cuts Price Target to $8 From $9	23-08-25	MT
BofA Securities Downgrades Clarivate to Underperform From Neutral, Adjusts Price Target to $6 From $10	23-08-07	MT
Wells Fargo Downgrades Clarivate to Equalweight From Overweight, Adjusts Price Target to $8 From $15	23-08-04	MT
Oppenheimer Adjusts Clarivate Price Target to $11 From $12, Maintains Outperform Rating	23-08-04	MT
RBC Cuts Price Target on Clarivate to $9 From $14, Maintains Outperform Rating	23-08-04	MT
Oppenheimer Adjusts Clarivate Price Target to $12 From $11, Maintains Outperform Rating	23-07-05	MT
Oppenheimer Initiates Coverage on Clarivate With Outperform Rating, $11 Price Target	23-06-13	MT
Goldman Sachs Cuts Clarivate's Price Target to $11 From $12.40, Buy Rating Maintained	23-05-10	MT
Morgan Stanley Adjusts Price Target on Clarivate to $11 From $12, Maintains Equal-Weight Rating	23-05-10	MT
Wells Fargo Adjusts Price Target on Clarivate to $15 From $14, Maintains Overweight Rating	23-03-02	MT
RBC Raises Price Target on Clarivate to $14 From $12, Cites 'Better-Than-Feared' Q4 Results, 2023 Guidance; Outperform Rating Kept	23-03-02	MT
Morgan Stanley Downgrades Clarivate to Equalweight From Overweight, Adjusts Price Target to $12 From $11	23-02-06	MT
Morgan Stanley Adjusts Price Target on Clarivate to $11 From $13, Maintains Overweight Rating	23-01-04	MT
Fears of Rate Hike Easing Delay Subdue Exchange-Traded Funds, Stock Futures Premarket Tuesday	22-12-06	MT
Goldman Sachs Adjusts Price Target on Clarivate to $14.50 From $17, Maintains Buy Rating	22-11-09	MT
Morgan Stanley Adjusts Price Target on Clarivate to $13 From $14, Maintains Overweight Rating	22-11-09	MT